ZHU Xiaojuan について
Qilu Hospital, Shandong Univ., Haematology Oncology Centre, 250012, Jinan, Shandong, People’s Republic of China について
ZHU Xiaojuan について
Qilu Hospital, Shandong Univ., The Key Lab. of Cardiovascular Remodeling and Function Res., Chinese Ministry of ... について
MA Daoxin について
Qilu Hospital, Shandong Univ., Haematology Oncology Centre, 250012, Jinan, Shandong, People’s Republic of China について
MA Daoxin について
Qilu Hospital, Shandong Univ., The Key Lab. of Cardiovascular Remodeling and Function Res., Chinese Ministry of ... について
ZHANG Jingbo について
Qilu Hospital, Shandong Univ., Haematology Oncology Centre, 250012, Jinan, Shandong, People’s Republic of China について
ZHANG Jingbo について
Qilu Hospital, Shandong Univ., The Key Lab. of Cardiovascular Remodeling and Function Res., Chinese Ministry of ... について
PENG Jun について
Qilu Hospital, Shandong Univ., Haematology Oncology Centre, 250012, Jinan, Shandong, People’s Republic of China について
PENG Jun について
Qilu Hospital, Shandong Univ., The Key Lab. of Cardiovascular Remodeling and Function Res., Chinese Ministry of ... について
Qilu Hospital, Shandong Univ., Inst. of Basic Medical Sciences, Jinan, People’s Republic of China について
JI Chunyan について
Qilu Hospital, Shandong Univ., Haematology Oncology Centre, 250012, Jinan, Shandong, People’s Republic of China について
HOU Ming について
Qilu Hospital, Shandong Univ., Haematology Oncology Centre, 250012, Jinan, Shandong, People’s Republic of China について
HOU Ming について
Qilu Hospital, Shandong Univ., The Key Lab. of Cardiovascular Remodeling and Function Res., Chinese Ministry of ... について
Journal of Clinical Immunology について
免疫性血小板減少症 について
患者 について
Th17 について
Th1細胞 について
相関 について
インターロイキン-21 について